March 15, 2013

Stop Alzheimer's Before Symptoms Start? - Dr. Reisa Sperling

Thumbnail

Stop Alzheimer's Before Symptoms Start? - Dr. Reisa Sperling

About This Episode

Dr. Sperling is leading a groundbreaking new study on individuals whose brain scans show plaque buildups but do not yet demonstrate clinical symptoms of Alzheimer’s or other dementias. She will be testing the effectiveness of the Eli Lilly drug solanezumab, which in previous studies has shown might have promise with people that have a milder form of Alzheimer’s.

Dr. Sperling is the Director of the Center for Alzheimer's Research and Treatment, the Director of the Education and Information Transfer Core, Massachusetts Alzheimer's Disease Research Center, Co-Leader of the Neuroimaging Program, Massachusetts Alzheimer's Disease Research Center, and a Professor of Neurology at Harvard Medical School.

This call was made possible by the generous support of Jill Lesser, Board member of USAgainstAlzheimer's Network.

BrainStorm Feed

61

Dr. Brent Forester – The Complexity of Dementia Care and the Importance of a Holistic Approach (part 2)

Join us for part 2 of BrainStorm’s interview with Dr. Brent Forester, Chairman of the Department of Psychiatry, and Director of Behavioral Health at Tufts Medical Center.
LISTEN NOW
60

Dr. Brent Forester – The Complexity of Dementia Care and the Importance of a Holistic Approach (part 1)

If you're facing the challenge of caring for a parent with dementia, you are not alone. In this episode of BrainStorm Brent Forester, MD, MSc, Psychiatrist in Chief, Chairman of the Department of Psychiatry, and Director of Behavioral Health at Tufts Medical Center, discussed the complexity of dementia care and the importance of a holistic approach with host Meryl Comer.
LISTEN NOW